Effect of insulin therapy and dietary adjustments on safety and performance during simulated soccer tests in people with type 1 diabetes: study protocol for a randomized controlled trial

被引:2
|
作者
Calvo-Marin, Javier [1 ]
Torrealba-Acosta, Gabriel [2 ]
Campbell, Matthew [3 ]
Gaboury, Jesse [2 ]
Ali, Ajmol [4 ]
Chen-Ku, Chih Hao [5 ]
机构
[1] Hosp San Vicente de Paul, Div Endocrinol, Heredia, Costa Rica
[2] Harvard Med Sch, Spaulding Rehabil Hosp, Neuromodulat Ctr, Boston, MA USA
[3] Leeds Beckett Univ, Sch Sport, Leeds, W Yorkshire, England
[4] Massey Univ, Coll Hlth, Sch Sport & Exercise, Albany, New Zealand
[5] Univ Costa Rica, Hosp San Juan de Dios, Dept Pharmacol & Clin Toxicol, Div Endocrinol, San Jose, Costa Rica
关键词
Type; 1; diabetes; Exercise; Hypoglycemia; Insulin; Continuous glucose monitoring; RAPID-ACTING INSULIN; HIGH-INTENSITY; EXERCISE; HYPOGLYCEMIA; INDIVIDUALS; RELIABILITY; ADOLESCENTS; REDUCTIONS; VALIDITY; UPDATE;
D O I
10.1186/s13063-017-2078-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Despite the reduction in glycemic derangement in patients with type 1 diabetes mellitus (T1D) through dietary and therapeutic adjustments implemented before, during and after continuous exercise, evidence for its effectiveness with intermittent forms of exercise, such as soccer, is still lacking. Methods/design: We designed a study protocol for a randomized, crossover, double-blinded, controlled trial, for the evaluation of the effect that a strategy of dietary and therapeutic modifications may have on safety and performance of persons with T1D in soccer training sessions and cognitive testing. Inclusion criteria comprise: age older than 18 years, more than 2 years since T1D diagnosis, low C-peptide level, a stable insulin regimen, HbA1c less than 9.0% and regular participation in soccer activities. Our primary outcome evaluates safety regarding hypoglycemia events in patients using dietary and therapeutic adjustments, compared with the performance under the implementation of current American Diabetes Association (ADA) usual recommendations for nutritional and pharmacological adjustments for exercise. Additionally, we will evaluate as secondary outcomes: soccer performance, indexed by performance in well-established soccer skill tests, cognitive functions (indexed by Stroop, digital vigilance test (DVT), Corsi block-tapping task (CBP), and rapid visual information processing (RVIP) tests), and glycemic control measured with a continuous glucose monitor (CGM). Discussion: Dietary and insulin adjustments standardized under a 4-step method strategy have never been tested in a clinical trial setting with intermittent forms of exercise, such as soccer. We hypothesize that through this strategy we will observe better performance by persons with T1D in soccer and cognitive evaluations, and more stable control of glycemic parameters before, during and after exercise execution, indexed by CGM measurements.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Efficacy and safety of insulin glargine in subjects with type 1 diabetes: A 28 week randomized, NPH insulin-controlled trial
    Ratner, RE
    Hirsch, IB
    Mecca, TE
    Wilson, CA
    DIABETES, 1999, 48 : A120 - A120
  • [22] Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial - study protocol
    Beunen, Kaat
    Van Wilder, Nancy
    Ballaux, Dominique
    Vanhaverbeke, Gerd
    Taes, Youri
    Aers, Xavier-Philippe
    Nobels, Frank
    Marlier, Joke
    Lee, Dahae
    Cuypers, Joke
    Preumont, Vanessa
    Siegelaar, Sarah E.
    Painter, Rebecca C.
    Laenen, Annouschka
    Gillard, Pieter
    Mathieu, Chantal
    Benhalima, Katrien
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [23] Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial – study protocol
    Kaat Beunen
    Nancy Van Wilder
    Dominique Ballaux
    Gerd Vanhaverbeke
    Youri Taes
    Xavier-Philippe Aers
    Frank Nobels
    Joke Marlier
    Dahae Lee
    Joke Cuypers
    Vanessa Preumont
    Sarah E. Siegelaar
    Rebecca C. Painter
    Annouschka Laenen
    Pieter Gillard
    Chantal Mathieu
    Katrien Benhalima
    BMC Pregnancy and Childbirth, 23
  • [24] Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol
    de Bock, Martin
    McAuley, Sybil A.
    Abraham, Mary Binsu
    Smith, Grant
    Nicholas, Jennifer
    Ambler, Geoff R.
    Cameron, Fergus J.
    Fairchild, Jan M.
    King, Bruce R.
    Geelhoed, Elizabeth A.
    Davis, Elizabeth A.
    O'Neal, David Norman
    Jones, Timothy W.
    BMJ OPEN, 2018, 8 (08):
  • [25] Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: A randomized trial
    Ledesma, Gilbert
    Umpierrez, Guillermo E.
    Morley, John E.
    Lewis-D'Agostino, Diane
    Keller, Annett
    Meinicke, Thomas
    van der Walt, Sandra
    von Eynatten, Maximilian
    DIABETES OBESITY & METABOLISM, 2019, 21 (11): : 2465 - 2473
  • [26] The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trial
    Thomsen, Camilla H. N.
    Norlev, Jannie T. D.
    Hangaard, Stine
    Jensen, Morten H.
    Hejlesen, Ole
    Cohen, Sarah R.
    Kofoed-Enevoldsen, Allan
    Kristensen, Sika N. S.
    Aradottir, Tinna B.
    Kaas, Anne
    Vestergaard, Peter
    Kronborg, Thomas
    TRIALS, 2024, 25 (01)
  • [27] Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study
    Blevins, T. C.
    Dahl, D.
    Rosenstock, J.
    Ilag, L. L.
    Huster, W. J.
    Zielonka, J. S.
    Pollom, R. K.
    Prince, M. J.
    DIABETES OBESITY & METABOLISM, 2015, 17 (08): : 726 - 733
  • [28] The effect and safety of acupuncture as adjunctive therapy for STEMI patients after PCI: study protocol of a randomized controlled trial
    Zhao, Yi
    Ling, Fayang
    Qin, Yalu
    Xie, Wen
    Qi, Wenchuan
    Nie, Qian
    Zhang, Hongcai
    Han, Mingjun
    Zhao, Jue
    Liu, Lei
    Hu, Lin
    Xiao, Juan
    Li, Wufeng
    Liang, Fanrong
    Zheng, Qianhua
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2024, 24 (01)
  • [29] Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial
    Obermayer, Anna
    Tripolt, Norbert J.
    Pferschy, Peter N.
    Kojzar, Harald
    Aziz, Faisal
    Mueller, Alexander
    Schauer, Markus
    Oulhaj, Abderrahim
    Aberer, Felix
    Sourij, Caren
    Habisch, Hansjoerg
    Madl, Tobias
    Pieber, Thomas
    Obermayer-Pietsch, Barbara
    Stadlbauer, Vanessa
    Sourij, Harald
    DIABETES CARE, 2023, 46 (02) : 463 - 468
  • [30] Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial
    Stella Cecchetti
    Bruno Pereira
    Antoine Roche
    Christophe Deschaumes
    Dihya Abdi
    Emmanuel Coudeyre
    Jean-Jacques Dubost
    Sylvain Mathieu
    Sandrine Malochet-Guinamand
    Anne Tournadre
    Marion Couderc
    Marielle Vayssade
    Coline Daron
    Martin Soubrier
    Trials, 15